Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas J Robert

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
The Oncologist|July 17, 2024
Health equity principles for oncology real world evidence studiesPatrice Forrester, Henry Asante Antwi, Nicholas J Robert, et al.
The Oncologist|March 16, 2012
Capecitabine monotherapy: review of studies in first-line HER-2-negative metastatic breast cancerJoyce A O'Shaughnessy, Manfred Kaufmann, Friederike Siedentopf, et al.
Cancer Medicine|September 6, 2024
Which social determinants of health have the highest impact in community oncology to advance patient care equity and improve health outcomes? A scoping reviewKayleigh R Majercak, Emily F Gorman, Nicholas J Robert, et al.
Cancer Medicine|June 25, 2020
Clinical outcomes among unresectable, locally advanced, and metastatic cutaneous squamous cell carcinoma patients treated with systemic therapyC Lance Cowey, Nicholas J Robert, Janet L Espirito, et al.
Clinical Genitourinary Cancer|June 11, 2021
Real-world Clinical Effectiveness of Lenvatinib/Everolimus in a Heavily Pretreated Advanced/Metastatic Renal Cell Carcinoma Population in the US Community Oncology SettingNicholas J Vogelzang, Alisha M Monnette, Yunfei Wang, et al.
Drugs - Real World Outcomes|July 30, 2020
Retrospective Observational Study of ALK-Inhibitor Therapy Sequencing and Outcomes in Patients with ALK-Positive Non-small Cell Lung CancerDavid M Waterhouse, Janet L Espirito, Marc D Chioda, et al.
Future Oncology (London, England)|March 26, 2021
Treatment patterns and outcomes of patients with advanced malignant pleural mesothelioma in a community practice settingDavid M Waterhouse, Esmond D Nwokeji, Marley Boyd, et al.
Cancer Medicine|July 26, 2022
Real-World nivolumab dosing patterns and safety outcomes in patients receiving adjuvant therapy for melanomaWolfram Samlowski, Nicholas J Robert, Liwei Chen, et al.
Cancer|August 27, 2004
Efficacy of radiotherapy for ovarian ablation: results of a breast intergroup studyLorie L Hughes, Robert J Gray, Lawrence J Solin, et al.
Future Oncology (London, England)|March 4, 2022
Real-world outcomes of systemic therapy in locally advanced, recurrent or metastatic cutaneous squamous cell carcinomaThao T Vo, Janet L Espirito, Marley Boyd, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
The Oncologist|July 17, 2024
Health equity principles for oncology real world evidence studiesPatrice Forrester, Henry Asante Antwi, Nicholas J Robert, et al.
The Oncologist|March 16, 2012
Capecitabine monotherapy: review of studies in first-line HER-2-negative metastatic breast cancerJoyce A O'Shaughnessy, Manfred Kaufmann, Friederike Siedentopf, et al.
Cancer Medicine|September 6, 2024
Which social determinants of health have the highest impact in community oncology to advance patient care equity and improve health outcomes? A scoping reviewKayleigh R Majercak, Emily F Gorman, Nicholas J Robert, et al.
Cancer Medicine|June 25, 2020
Clinical outcomes among unresectable, locally advanced, and metastatic cutaneous squamous cell carcinoma patients treated with systemic therapyC Lance Cowey, Nicholas J Robert, Janet L Espirito, et al.
Clinical Genitourinary Cancer|June 11, 2021
Real-world Clinical Effectiveness of Lenvatinib/Everolimus in a Heavily Pretreated Advanced/Metastatic Renal Cell Carcinoma Population in the US Community Oncology SettingNicholas J Vogelzang, Alisha M Monnette, Yunfei Wang, et al.
Drugs - Real World Outcomes|July 30, 2020
Retrospective Observational Study of ALK-Inhibitor Therapy Sequencing and Outcomes in Patients with ALK-Positive Non-small Cell Lung CancerDavid M Waterhouse, Janet L Espirito, Marc D Chioda, et al.
Future Oncology (London, England)|March 26, 2021
Treatment patterns and outcomes of patients with advanced malignant pleural mesothelioma in a community practice settingDavid M Waterhouse, Esmond D Nwokeji, Marley Boyd, et al.
Cancer Medicine|July 26, 2022
Real-World nivolumab dosing patterns and safety outcomes in patients receiving adjuvant therapy for melanomaWolfram Samlowski, Nicholas J Robert, Liwei Chen, et al.
Cancer|August 27, 2004
Efficacy of radiotherapy for ovarian ablation: results of a breast intergroup studyLorie L Hughes, Robert J Gray, Lawrence J Solin, et al.
Future Oncology (London, England)|March 4, 2022
Real-world outcomes of systemic therapy in locally advanced, recurrent or metastatic cutaneous squamous cell carcinomaThao T Vo, Janet L Espirito, Marley Boyd, et al.
Pageof 6